These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20182560)

  • 21. Individualization through standardization: electronic orders for subcutaneous insulin in the hospital.
    Kennihan M; Zohra T; Devi R; Srinivasan C; Diaz J; Howard BS; Braithwaite SS
    Endocr Pract; 2012; 18(6):976-87. PubMed ID: 23246685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital.
    Schnipper JL; Barsky EE; Shaykevich S; Fitzmaurice G; Pendergrass ML
    J Hosp Med; 2006 May; 1(3):145-50. PubMed ID: 17219488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHANGING TO BASAL-BOLUS INSULIN THERAPY FOR THE INPATIENT MANAGEMENT OF HYPERGLYCEMIA-A NATURAL EXPERIMENT.
    Brand DA; Peragallo-Dittko V; Fazzari MJ; Islam S; Jacobson AM; Radin MS
    Endocr Pract; 2019 Aug; 25(8):836-845. PubMed ID: 31070947
    [No Abstract]   [Full Text] [Related]  

  • 25. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using standardized insulin orders to improve patient safety in a tertiary care centre.
    Doyle MA; Brez S; Sicoli S; De Sousa F; Keely E; Malcom JC
    Can J Diabetes; 2014 Apr; 38(2):118-25. PubMed ID: 24690506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ensuring optimal insulin utilization in the hospital setting: role of the pharmacist.
    Kelly JL
    Am J Health Syst Pharm; 2010 Aug; 67(16 Suppl 8):S9-16. PubMed ID: 20689152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of "Real-World" Insulin Strategies in the Management of Hospital Hyperglycemia.
    Sadhu AR; Patham B; Vadhariya A; Chikermane SG; Johnson ML
    J Endocr Soc; 2021 Aug; 5(8):bvab101. PubMed ID: 34235360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperglycemia control of the nil per os patient in the intensive care unit: introduction of a simple subcutaneous insulin algorithm.
    Kim S; Rushakoff RJ; Sullivan M; Windham H
    J Diabetes Sci Technol; 2012 Nov; 6(6):1413-9. PubMed ID: 23294788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving hyperglycemia management in the intensive care unit: preliminary report of a nurse-driven quality improvement project using a redesigned insulin infusion algorithm.
    Osburne RC; Cook CB; Stockton L; Baird M; Harmon V; Keddo A; Pounds T; Lowey L; Reid J; McGowan KA; Davidson PC
    Diabetes Educ; 2006; 32(3):394-403. PubMed ID: 16772655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Impact of an Inpatient Hyperglycemia Protocol on Glycemic Control.
    Ilcewicz HN; Hennessey EK; Smith CB
    J Pharm Pharm Sci; 2019; 22(1):85-92. PubMed ID: 30730832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and effectiveness of a computerized subcutaneous insulin program to treat inpatient hyperglycemia.
    Juneja R; Golas AA; Carroll J; Nelson D; Abad VJ; Roudebush CP; Flanders SJ
    J Diabetes Sci Technol; 2008 May; 2(3):384-91. PubMed ID: 19885202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality improvement project for improving inpatient glycaemic control in non-critically ill patients admitted on medical floor with type 2 diabetes mellitus.
    Khan AA; Shahzad A; Rose S; Al Mohanadi DHSH; Zahid M
    BMJ Open Qual; 2020 Aug; 9(3):. PubMed ID: 32792342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Pocket Insulin Dosing Guide on Utilization of Basal/Bolus Insulin by Internal Medicine Resident Physicians.
    Mamillapalli CK; Rico E; Nallala D; Mansuri O; Jakoby MG
    Cureus; 2018 Jun; 10(6):e2879. PubMed ID: 30155381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a standardized order form for the withdrawal of life support in the intensive care unit.
    Treece PD; Engelberg RA; Crowley L; Chan JD; Rubenfeld GD; Steinberg KP; Curtis JR
    Crit Care Med; 2004 May; 32(5):1141-8. PubMed ID: 15190964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of an educational program and a standardized insulin order form on glycemic outcomes in non-critically ill hospitalized patients.
    Wesorick DH; Grunawalt J; Kuhn L; Rogers MA; Gianchandani R
    J Hosp Med; 2010 Oct; 5(8):438-45. PubMed ID: 20690189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.